Gara Jalqabaatti › Dhukkubaa Graft-Versus-Host
Qorannoo klinikaalii Dhukkubaa Graft-Versus-Host Ameerikaa Keessatti hirmaatuu
Qorannoo 35 Dhukkubaa Graft-Versus-Host f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Boston, MAQorannoo 10
- New York City, NYQorannoo 7
- Columbus, OHQorannoo 6
- Baldwin Park, CAQorannoo 5
- Atlanta, GAQorannoo 5
- Washington, DCQorannoo 5
- Pittsburgh, PAQorannoo 4
- Detroit, MIQorannoo 4
- Portland, ORQorannoo 4
- St. Louis, MOQorannoo 4
- Tampa, FLQorannoo 4
- Seattle, WAQorannoo 4
- Miami, FLQorannoo 4
- Queens, NYQorannoo 4
- Los Angeles, CAQorannoo 3
- Cleveland, OHQorannoo 3
- Nashville, TNQorannoo 3
- Chicago, ILQorannoo 3
- Houston, TXQorannoo 3
- Staten Island, NYQorannoo 3
- New Rochelle, NYQorannoo 3
- Edison, NJQorannoo 3
- East Norwalk, CTQorannoo 3
- Greenburgh, NYQorannoo 3
Naannoon
- CaliforniaQorannoo 10
- FloridaQorannoo 7
- GeorgiaQorannoo 5
- IllinoisQorannoo 3
- KansasQorannoo 3
- MarylandQorannoo 5
- MassachusettsQorannoo 10
- MichiganQorannoo 5
- MissouriQorannoo 4
- New JerseyQorannoo 4
- New YorkQorannoo 10
- OhioQorannoo 7
- OregonQorannoo 4
- PennsylvaniaQorannoo 6
- TennesseeQorannoo 3
- TexasQorannoo 4
- WashingtonQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 7 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07235501Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT00001529Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 70 · Dubartoota · Haaromfame 29-Ful-2026 · NCT06649201Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05531786Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06910969Evaluation of Patients With Immune Function Abnormalities
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin hundi · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT00128973Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 7 hanga 80 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT00106925Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT06450925Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT06392711Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07565220Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 23-Ado-2026 · NCT06991361Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07216443A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07359859Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT06996119Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT06815003A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT07006506A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 16-Wax-2026 · NCT04710576Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 14 hanga 100 · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT05289167A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 4 fi ol · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT05675930A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT06615050Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 26 · Saalaa hunda · Haaromfame 14-Cam-2026 · NCT07566377Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT04380740Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Elb-2026 · NCT06008808Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT07356245Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT06434363Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.